Schedule 13G ownership disclosure

Lipocine Inc.

Security class unavailable · CUSIP: 53630X104

Event date: 2020-02-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,361,344
Percent of class
7.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000075
Form type
SC 13G
Filer
Lipocine Inc.
CIK
CIK 1535955
Filed
Feb 25, 2020
Reporting period
Feb 25, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub